Abstract
In a postmarketing surveillance of ketotifen (Zaditen), an oral preparation for the prophylaxis of bronchial asthma, 8291 patients completed records every three months for one year. The objectives were to record adverse events and efficacy and to communicate appropriate information to participating doctors and regulatory authorities. The patients recruited appeared to represent a typical cross section of patients with asthma in the United Kingdom. By subjective assessment 70% of patients found the medication efficacious. There were no unexpected or unacceptable side effects and those found were similar to those reported in clinical trials of ketotifen. Though this exercise showed that the pharmaceutical industry, regulatory authorities, and prescribing doctors were able to collaborate, the major outcome of the survey was already known. It remains to be seen whether this type of survey is of value in the continuing search for control and safety in prescribing.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Colin-Jones D. G., Langman M. J., Lawson D. H., Vessey M. P. Postmarketing surveillance of the safety of cimetidine: 12 month mortality report. Br Med J (Clin Res Ed) 1983 May 28;286(6379):1713–1716. doi: 10.1136/bmj.286.6379.1713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cupic Z. Long-term follow-up of Charnley arthroplasty of the hip. Clin Orthop Relat Res. 1979 Jun;(141):28–43. [PubMed] [Google Scholar]
- Lawson D. H., Henry D. A. Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"? Br Med J. 1977 Mar 12;1(6062):691–692. doi: 10.1136/bmj.1.6062.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McBeath A. A., Neidhart D. A. Acetabular cyst with communicating ganglion. A case report. J Bone Joint Surg Am. 1976 Mar;58(2):267–269. [PubMed] [Google Scholar]
- Reidenberg M. M., Lowenthal D. T. Adverse nondrug reactions. N Engl J Med. 1968 Sep 26;279(13):678–679. doi: 10.1056/NEJM196809262791304. [DOI] [PubMed] [Google Scholar]
- Skegg D. C., Doll R. The case for recording events in clinical trials. Br Med J. 1977 Dec 10;2(6101):1523–1524. doi: 10.1136/bmj.2.6101.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilson A. B. Post-marketing surveillance of adverse reactions to new medicines. Br Med J. 1977 Oct 15;2(6093):1001–1003. doi: 10.1136/bmj.2.6093.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]